Cargando…

Mutation signatures inform the natural host of SARS-CoV-2

Detalles Bibliográficos
Autores principales:	Deng, Shanjun, Xing, Ke, He, Xionglei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	BRIEF COMMUNICATION
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690307/ https://www.ncbi.nlm.nih.gov/pubmed/35211321 http://dx.doi.org/10.1093/nsr/nwab220

Ejemplares similares

Mapping host restriction of SARS-CoV-2
por: Gea-Mallorquí, Ester
Publicado: (2020)

CRISPRing for host genes regulating SARS-CoV-2
por: Lu, Fangfang, et al.
Publicado: (2020)

A map of SARS-CoV-2 and host cell interactions
por: Malle, Louise
Publicado: (2020)

Transient acquisition of cross-species infectivity during the evolution of SARS-CoV-2
por: Chen, Qi, et al.
Publicado: (2021)

SARS-CoV-2 vaccines in patients with SLE
por: Tang, Wei, et al.
Publicado: (2021)

Interactive SARS-CoV-2 mutation timemaps
por: Warren, René L., et al.
Publicado: (2021)

Secondary structure of the SARS-CoV-2 5’-UTR
por: Miao, Zhichao, et al.
Publicado: (2020)

Direct on-the-spot detection of SARS-CoV-2 in patients
por: Ben-Assa, Nadav, et al.
Publicado: (2020)

Bayesian estimation of the seroprevalence of antibodies to SARS-CoV-2
por: Dong, Qunfeng, et al.
Publicado: (2020)

Neutralisation of SARS‐CoV‐2 by anatomical embalming solutions
por: Quondamatteo, Fabio, et al.
Publicado: (2021)

Does a host restriction factor facilitate entry of SARS-CoV-2?
por: Gea-Mallorquí, Ester
Publicado: (2020)

Co‐infection of malaria and dengue in pregnant women with SARS‐CoV‐2
por: Mahajan, Niraj N., et al.
Publicado: (2020)

Prevalence of a Single-Nucleotide Variant of SARS-CoV-2 in Korea and Its Impact on the Diagnostic Sensitivity of the Xpert Xpress SARS-CoV-2 Assay
por: Hong, Ki Ho, et al.
Publicado: (2022)

The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization
por: Zou, Jing, et al.
Publicado: (2021)

To Transplant or Not to Transplant During the SARS‐CoV‐2 Pandemic? That Is the Question
por: Marino, Dario, et al.
Publicado: (2020)

Haemophilus influenzae and SARS-CoV-2: Is there a role for investigation?
por: Borkakoty, Biswajyoti, et al.
Publicado: (2021)

Emergence of SARS-CoV-2 serotype(s): Is it a matter of time?
por: Silva Júnior, José Valter Joaquim, et al.
Publicado: (2023)

Experimental and in silico evidence suggests vaccines are unlikely to be affected by D614G mutation in SARS-CoV-2 spike protein
por: McAuley, Alexander J., et al.
Publicado: (2020)

Effortful speech with distortion of prosody following SARS-CoV-2 infection
por: Cotelli, Maria Sofia, et al.
Publicado: (2020)

Virus Isolation from the First Patient with SARS-CoV-2 in Korea
por: Park, Wan Beom, et al.
Publicado: (2020)

Sociodemographic characteristics and healthcare utilization of infants with SARS-CoV-2 in the U.S
por: Yieh, Leah, et al.
Publicado: (2023)

Lipid Accumulation in Host Cells Promotes SARS-CoV-2 Replication
por: Seitz, Tatjana, et al.
Publicado: (2023)

PF-D-Trimer, a protective SARS-CoV-2 subunit vaccine: immunogenicity and application
por: Zhang, Zhihao, et al.
Publicado: (2023)

No indication for SARS-CoV-2 transmission to pet ferrets, in five cities in Poland, 2021 - antibody testing among ferrets living with owners infected with SARS-CoV-2 or free of infection
por: Kaczorek-Łukowska, Edyta, et al.
Publicado: (2023)

Are mobile phones part of the chain of transmission of SARS-CoV-2 in hospital settings?
por: Espinoza, Evelyn Patricia Sánchez, et al.
Publicado: (2021)

Effectiveness of Disinfectants Suitable for Inactivating SARS-CoV-2 at Cold-Chain Temperature
por: Wu, Xiaosong, et al.
Publicado: (2022)

Time of Bariatric Surgery and Hospitalization for SARS-CoV-2: a Nationwide Study
por: Poghosyan, Tigran, et al.
Publicado: (2021)

Antibody Responses One Year after Mild SARS-CoV-2 Infection
por: Choe, Pyoeng Gyun, et al.
Publicado: (2021)

Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant
por: Gao, Yu, et al.
Publicado: (2022)

Immunogenicity of candidate SARS-CoV-2 DNA vaccines based on the spike protein
por: Lim, Heeji, et al.
Publicado: (2022)

Vaccines against SARS‐CoV‐2 are safe to administer in patients with antibodies to pegaspargase
por: Swanson, Hope D., et al.
Publicado: (2022)

Comparative Study of SARS-CoV-2, SARS-CoV-1, MERS-CoV, HCoV-229E and Influenza Host Gene Expression in Asthma: Importance of Sex, Disease Severity, and Epithelial Heterogeneity
por: Coden, Mackenzie E., et al.
Publicado: (2021)

SARS-CoV-2 on the neural battleground
por: Pavillet, Clara Eléonore, et al.
Publicado: (2020)

SARS-CoV-2 likes it cool
por: Soares-Schanoski, Alessandra
Publicado: (2020)

Inactivated vaccine for SARS-CoV-2
por: Risson, Emma
Publicado: (2020)

Clotting and SARS-CoV-2 entry
por: Hofer, Ursula
Publicado: (2022)

Histone mimicry by SARS-CoV-2
por: York, Ashley
Publicado: (2022)

SARS-CoV-2 in penile tissue
por: Thomas, Tim
Publicado: (2022)

Anti-SARS-CoV-2 spike protein and neutralizing antibodies at 1 and 3 months after three doses of SARS-CoV-2 vaccine in a large cohort of solid organ transplant patients
por: Kamar, Nassim, et al.
Publicado: (2022)

First Evidence of Natural SARS-CoV-2 Infection in Domestic Rabbits
por: Fritz, Matthieu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_q5pco0j99lmghegka9g199fat7